This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Understand the importance of retirement accounts in your 30s. Early planning can lead to a more secure financial future.
23,091 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
When a tech hardware stock plunges, questions surge. This guide explains the drivers behind super micro stock crashin...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
A prominent market strategist says investors should their money in gold, proposing a 10% allocation to hedge inflatio...
China’s domestic auto market is feeling the squeeze even as exporters push ahead. Nio sits at a crossroads where poli...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
Investors are watching IonQ as it edges toward scalable quantum systems through a photonic interconnect. This breakth...
As Disney readies Toy Story 5, investors wonder if this beloved IP can spark a broader upswing. This piece breaks dow...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
When insiders trade, investors pay attention. This article breaks down what seacoast banking corp. sells signals, how...